Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 2117  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
  NAVIGATE here  
  ::   Search
  ::   Ahead of print
  ::   Current Issue
  ::   Submit Article 
  ::   Apply as Referee 
  ::   JPGM WriteCon 
  ::   Current Symposium 

 


This article has been cited by
1Drug delivery strategies for therapy of visceral leishmaniasis
Swati Gupta,Ajay Pal,Suresh P Vyas
Expert Opinion on Drug Delivery.2010;7(3)371
[DOI]
2Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis
Tejinder Kaur,Prerna Makkar,Kulbir Randhawa,Sukhbir Kaur
Parasitology Research.2013;112(1)91
[DOI]
3Alterations on the growth and ultrastructure of Leishmania chagasi induced by squalene synthase inhibitors
Ana Claudia Granthon,Marina V. Braga,Juliany C.F. Rodrigues,Simon Cammerer,Silvia Orenes Lorente,Ian H. Gilbert,Julio A. Urbina,Wanderley de Souza
Veterinary Parasitology.2007;146(1-2)25
[DOI]
4Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India
Jitendra Gupta,Paul Roddy,Nawin Kumar,Pedro Pablo Palma,Jean-François Saint-Sauveur,Siju Seena,Prabhat K. Sinha,Vidya Nand Rabi Das,Krishna Pandey,Gaurab Mitra,Alice Kociejowski,María Angeles Lima,Manica Balasegaram,Fernando Parreño
The American Journal of Tropical Medicine and Hygiene.2010;83(2)357
[DOI]
5Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences
Katerina Juzlova,Jana Votrubova,Denisa Kacerovska,Milan Lukas,Martin Bortlik,Hana Rohacova,Eva Nohynkova,Nadezda Vojackova,Jorga Fialova,Jana Hercogova
Dermatologic Therapy.2014;27(3)131
[DOI]
6Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives
Corinne Peyron,Rachid Benhida,Christian Bories,Philippe M. Loiseau
Bioorganic Chemistry.2005;33(6)439
[DOI]
7Oro-Pharyngeal Mass in a Patient With HIV Infection
Luis Mérida Rodrigo,Julián Olalla Sierra,Alfonso del Arco Jiménez,Isabel Rodrigo Fernández
Acta Otorrinolaringologica (English Edition).2008;59(4)202
[DOI]
8Gibbilimbol analogues as antiparasitic agents—Synthesis and biological activity against Trypanosoma cruzi and Leishmania (L.) infantum
Marina T. Varela,Roberto Z. Dias,Ligia F. Martins,Daiane D. Ferreira,Andre G. Tempone,Anderson K. Ueno,João Henrique G. Lago,João Paulo S. Fernandes
Bioorganic & Medicinal Chemistry Letters.2016;26(4)1180
[DOI]
9In vitro assays for evaluation of drug activity against Leishmania spp.
Luciana Fumarola,Rosa Spinelli,Olga Brandonisio
Research in Microbiology.2004;155(4)224
[DOI]
10Isolation of Leishmania glycosomes by a rapid method
Bikramjit Raychaudhury,Shreedhara Gupta,Shouvik Banerjee,Banasri Das,Salil C. Datta
Analytical Biochemistry.2004;332(2)404
[DOI]
11Isolation of Leishmania glycosomes by a rapid method
Shobha Upreti,Veni Pande,Diksha Joshi,Vinita Gouri,Mukesh Samant
Analytical Biochemistry.2021;332(2)209
[DOI]
12From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection
Greta Volpedo,Ryan H Huston,Erin A Holcomb,Thalia Pacheco-Fernandez,Sreenivas Gannavaram,Parna Bhattacharya,Hira L Nakhasi,Abhay R Satoskar
Expert Review of Vaccines.2021;20(11)1431
[DOI]
13An intracellular calcium store is present in Leishmania donovani glycosomes
Shreedhara Gupta,Bikramjit Raychaudhury,Shouvik Banerjee,Banasri Das,Salil C. Datta
Experimental Parasitology.2006;113(3)161
[DOI]
14Importance of Nonenteric Protozoan Infections in Immunocompromised People
J. L. N. Barratt,J. Harkness,D. Marriott,J. T. Ellis,D. Stark
Clinical Microbiology Reviews.2010;23(4)795
[DOI]
15STRUCTURAL FEATURE STUDY OF FUROXAN DERIVATIVES AS POTENT ANTI-TRYPANOSOMATID AGENTS: QSAR APPROACH
M. C. Sharma
INDIAN DRUGS.2016;53(09)12
[DOI]
16Antileishmanial activity evaluation of adunchalcone, a new prenylated dihydrochalcone from Piper aduncum L.
Camilla R. Dal Picolo,Mariana P. Bezerra,Kaio S. Gomes,Luiz Felipe D. Passero,Marcia D. Laurenti,Euder Glendes A. Martins,Patricia Sartorelli,João Henrique G. Lago
Fitoterapia.2014;97(09)28
[DOI]
17Oral Miltefosine for Leishmaniasis in Immunocompromised Patients: Compassionate Use in 39 Patients with HIV Infection
H. Sindermann,K. R. Engel,C. Fischer,W. Bommer
Clinical Infectious Diseases.2004;39(10)1520
[DOI]
18Imported leishmaniasis in Germany 2001–2004: data of the SIMPID surveillance network
T. Weitzel,N. Mühlberger,T. Jelinek,M. Schunk,S. Ehrhardt,C. Bogdan,K. Arasteh,T. Schneider,W. V. Kern,G. Fätkenheuer,G. Boecken,T. Zoller,M. Probst,M. Peters,T. Weinke,S. Gfrörer,H. Klinker,M.-L. Holthoff-Stich
European Journal of Clinical Microbiology & Infectious Diseases.2005;24(7)471
[DOI]
19Injectable Paromomycin for Visceral Leishmaniasis in India
Shyam Sundar,T.K. Jha,Chandreshwar P. Thakur,Prabhat K. Sinha,Sujit K. Bhattacharya
New England Journal of Medicine.2007;356(25)2571
[DOI]
20Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: Mechanism of action studies
Luci´a Boiani,Gabriela Aguirre,Mercedes González,Hugo Cerecetto,Agustina Chidichimo,Juan J. Cazzulo,Massimo Bertinaria,Stefano Guglielmo
Bioorganic & Medicinal Chemistry.2008;16(17)7900
[DOI]
21Challenges and new discoveries in the treatment of leishmaniasis
Sarman Singh,Ramu Sivakumar
Journal of Infection and Chemotherapy.2004;10(6)307
[DOI]
22A new approach for the delivery of artemisinin: Formulation, characterization, and ex-vivo antileishmanial studies
Muzamil Yaqub Want,Mohammad Islamuddin,Garima Chouhan,Anjan Kumar Dasgupta,Asoke Prasun Chattopadhyay,Farhat Afrin
Journal of Colloid and Interface Science.2014;432(6)258
[DOI]
23Le traitement de la leishmaniose viscérale en Europe en 2009. Place de l’amphotéricine B liposomale
E. Rosenthal,P. Delaunay,P.-Y. Jeandel,H. Haas,C. Pomares-Estran,P. Marty
Médecine et Maladies Infectieuses.2009;39(10)741
[DOI]
24IL-10- and TGF-ß-Mediated Susceptibility in Kala-azar and Post-kala-azar Dermal Leishmaniasis: The Significance of Amphotericin B in the Control ofLeishmania donovaniInfection in India
Samiran Saha,Smriti Mondal,Rajesh Ravindran,Swati Bhowmick,Dolanchampa Modak,Sudeshna Mallick,Mehboobar Rahman,Sourjya Kar,Ramaprasad Goswami,Subhasis Kamal Guha,Netai Pramanik,Bibhuti Saha,Nahid Ali
The Journal of Immunology.2007;179(8)5592
[DOI]
25Leishmaniasis cutánea difusa en un paciente con sida
Carlos Pérez,Yoanet Solías,Gerzaín Rodríguez
Biomédica.2006;26(4)485
[DOI]
26Leishmaniasis cutánea difusa en un paciente con sida
Goutam Mandal,Vaidya Govindarajan,Mansi Sharma,Hiranmoy Bhattacharjee,Rita Mukhopadhyay
Biomédica.2017;26(4)649
[DOI]
27Visceral Leishmaniasis Clinical Management in Endemic Districts of India, Nepal, and Bangladesh
Megha Raj Banjara,Siddhivinayak Hirve,Niyamat Ali Siddiqui,Narendra Kumar,Sangeeta Kansal,M. Mamun Huda,Pradeep Das,Suman Rijal,Chitra Kumar Gurung,Paritosh Malaviya,Byron Arana,Axel Kroeger,Dinesh Mondal
Journal of Tropical Medicine.2012;2012(4)1
[DOI]
282H-Benzimidazole 1,3-Dioxide Derivatives:? A New Family of Water-Soluble Anti-Trypanosomatid Agents
Mariana Boiani,Lucía Boiani,Ana Denicola,Susana Torres de Ortiz,Elva Serna,Ninfa Vera de Bilbao,Luis Sanabria,Gloria Yaluff,Héctor Nakayama,Antonieta Rojas de Arias,Celeste Vega,Miriam Rolan,Alicia Gómez-Barrio,Hugo Cerecetto,Mercedes González
Journal of Medicinal Chemistry.2006;49(11)3215
[DOI]
29In Vitro and In Vivo Studies of Antileishmanial Effect of Artemether on Leishmania infantum
Nahid Mortazavi Dehkordi,Fatemeh Ghaffarifar,Zuhair Mohammad Hassan,Farzad Esavand Heydari
Jundishapur Journal of Microbiology.2013;6(5)3215
[DOI]
30Evaluation of the leishmanicidal and cytotoxic effects of inhibitors for microorganism metabolic pathway enzymes
Ademar de Mesquita Barbosa,Solange dos Santos Costa,Josmar Rodrigues da Rocha,Carlos Alberto Montanari,Selma Giorgio
Biomedicine & Pharmacotherapy.2015;74(5)95
[DOI]
31Masa orofaríngea en paciente con infección por VIH
Luis Mérida Rodrigo,Julián Olalla Sierra,Alfonso del Arco Jiménez,Isabel Rodrigo Fernández
Acta Otorrinolaringológica Española.2008;59(4)202
[DOI]
32Effectiveness of amiodarone in treatment of cutaneous leishmaniasis caused by Leishmania major
E. Bemani,A. Oryan,S. Bahrami
Experimental Parasitology.2019;205(4)107747
[DOI]
33Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region
F. Pasquau,J. Ena,R. Sanchez,J. M. Cuadrado,C. Amador,J. Flores,C. Benito,C. Redondo,J. Lacruz,V. Abril,J. Onofre
European Journal of Clinical Microbiology & Infectious Diseases.2005;24(6)411
[DOI]
34Traitement des leishmanioses en France : proposition d’un référentiel consensuel
Pierre A. Buffet,Éric Rosenthal,Jean-Pierre Gangneux,Edward Lightburne,Pierre Couppié,Gloria Morizot,Laurence Lachaud,Pierre Marty,Jean-Pierre Dedet
La Presse Médicale.2011;40(2)173
[DOI]
35Visceral leishmaniasis: a trip to the Greek Islands is not always idyllic
Oui Ju,David I Grove,Wilfrid J Jaksic,Geoffrey W Dart
Medical Journal of Australia.2004;181(8)446
[DOI]
36Evaluation of a novel lentiviral vaccine expressing KMP11-HASPB fusion protein againstLeishmania infantumin BALB/c mice
N. Mortazavidehkordi,A. Farjadfar,H. Khanahmad,Z. Ghayour Najafabadi,N. Hashemi,A. Fallah,A. Najafi,V. Kia,S. H. Hejazi
Parasite Immunology.2016;38(11)670
[DOI]
37Anti-trypanosomatid benzofuroxans and deoxygenated analogues: Synthesis using polymer-supported triphenylphosphine, biological evaluation and mechanism of action studies
Diego Castro,Lucia Boiani,Diego Benitez,Paola Hernández,Alicia Merlino,Carmen Gil,Claudio Olea-Azar,Mercedes González,Hugo Cerecetto,Williams Porcal
European Journal of Medicinal Chemistry.2009;44(12)5055
[DOI]
38Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review
Pashupati Pokharel,Rakesh Ghimire,Pratik Lamichhane,Alemayehu Toma
Journal of Tropical Medicine.2021;2021(12)1
[DOI]
39Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review
Hiranmoy Bhattacharjee,Rita Mukhopadhyay
Journal of Tropical Medicine.2009;2021(12)575
[DOI]
40Isobologram Curve of Leishmanicidal Effects of Amiodarone and Ketoconazole
Somayeh Bahrami,Mohammad Hossein Razi Jalali,Hossein Najafzadeh,Zeinab Asadi
Jundishapur Journal of Health Sciences.2017;9(4)575
[DOI]
413-Trifluoromethylquinoxaline N,N'-Dioxides as Anti-Trypanosomatid Agents. Identification of Optimal Anti-T. cruzi Agents and Mechanism of Action Studies
Diego Benitez,Mauricio Cabrera,Paola Hernández,Lucía Boiani,María L. Lavaggi,Rossanna Di Maio,Gloria Yaluff,Elva Serna,Susana Torres,María E. Ferreira,Ninfa Vera de Bilbao,Enrique Torres,Silvia Pérez-Silanes,Beatriz Solano,Elsa Moreno,Ignacio Aldana,Adela López de Ceráin,Hugo Cerecetto,Mercedes González,Antonio Monge
Journal of Medicinal Chemistry.2011;54(10)3624
[DOI]
42HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil
Priscilla Alexandrino-de-Oliveira,Joanna Reis Santos-Oliveira,Maria Elizabeth Cavalheiros Dorval,Francisco das Chagas Brandão Da-Costa,Gracy Regina Oliveira Leite Pereira,Rivaldo Venâncio da Cunha,Anamaria Mello Miranda Paniago,Alda Maria Da-Cruz
Memórias do Instituto Oswaldo Cruz.2010;105(5)692
[DOI]
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow